- Report
- January 2024
- 114 Pages
United States
€3132EUR$3,500USD£2,678GBP
- Report
- January 2024
- 109 Pages
United States
€3132EUR$3,500USD£2,678GBP
- Report
- May 2021
- 50 Pages
China
From €2326EUR$2,600USD£1,989GBP
- Report
- July 2018
- 33 Pages
Global
From €8948EUR$10,000USD£7,652GBP
- Report
- August 2026
- 50 Pages
Global
From €2371EUR$2,650USD£2,028GBP
Tiotropium is a long-acting anticholinergic drug used to treat chronic obstructive pulmonary disease (COPD). It is a bronchodilator, meaning it relaxes the muscles in the airways, allowing more air to flow in and out of the lungs. It is available in both an inhaler and a dry powder inhaler. Tiotropium is the only long-acting anticholinergic approved for the treatment of COPD. It is also used to treat asthma and other respiratory conditions.
Tiotropium is a popular drug in the respiratory drugs market, as it is effective in treating COPD and other respiratory conditions. It is also well-tolerated, with few side effects. It is available in both generic and brand-name forms, making it accessible to a wide range of patients.
Some companies in the Tiotropium market include Boehringer Ingelheim, GlaxoSmithKline, and Novartis. Show Less Read more